HCRT and Huntington disease: However, in addition to the described behavioural interventions [109], sodium oxybate [110, 111], orexin antagonists [112, 113] and devices facilitating acoustic augmentation of slow wave sleep [114] are all demonstrating potential to improve both sleep and cognitive outcomes in neurodegenerative cohorts, but have yet to be trialled in an HD population.